Le Lézard
Classified in: Health, Business
Subject: PER

Capital Rx Appoints Antonio Garcia Cueto as Chief Financial Officer

NEW YORK, June 18, 2024 /PRNewswire/ -- Capital Rx, the full-service pharmacy benefit manager ('PBM') and pharmacy benefit administrator ('PBA') advancing our nation's electronic healthcare infrastructure to improve drug price visibility and patient outcomes, today announced that Antonio Garcia Cueto has joined the company's executive leadership team as Chief Financial Officer. He will lead the finance department at Capital Rx, overseeing all matters relating to financial strategy, planning, and reporting, among other responsibilities.

Antonio's financial, legal, and operating experience will be invaluable as Capital Rx invests in JUDI® and scales its business.

"We welcome Antonio at an extraordinary time for Capital Rx, and I am delighted that he's joined our organization as we embark on the next phase of our aggressive growth plan and mission: to develop the infrastructure that will benefit every payer, provider, and patient in our country," said AJ Loiacono, Co-Founder and CEO of Capital Rx. "To achieve this lofty goal, we've secured the capital reserves to invest aggressively in JUDI® and our teams. Antonio's two decades of financial, legal, and operating experience will be invaluable as we scale the business."

Based in New York, Garcia Cueto joins Capital Rx in the wake of monumental announcements, including its strategic alliance with Prime Therapeutics and the closing of a $50M+ strategic investment round involving more than 10 of the nation's leading health systems. In both instances, Capital Rx's enterprise health platform (EHP), JUDI, is a central pillar. Today, Capital Rx leverages JUDI to enable pharmacy benefit program deployment and administration for commercial, Medicare, and Medicaid plans. The EHP seamlessly connects to other platforms and systems with unrivaled financial efficiency and flexibility, allowing for a focus on member care and the transition to a value-based care delivery model.

"Capital Rx's mission is inspiring, and I'm honored to join an incredibly talented team committed to bringing necessary advancements to the healthcare industry," said Garcia Cueto. "The U.S. healthcare system is riddled with inefficiency, and waste is rampant. Capital Rx's ability to drive down costs, improve transparency, and deliver an exceptional patient care experience drew me to this role, and I'm looking forward to helping accelerate the pace of change for things that many people don't believe can be changed."

Prior to joining Capital Rx, Antonio served as Eden Health's Chief Financial and Operating Officer, overseeing financial strategy, corporate development, mergers and acquisitions, operations, and customer success initiatives for the provider of primary care, mental health care, and care navigation solutions to the employer market.

About Capital Rx
?Capital Rx is a full-service pharmacy benefit manager (PBM) and pharmacy benefit administrator (PBA), advancing our nation's electronic healthcare infrastructure to improve drug price visibility and patient outcomes. As a Certified B Corptm, Capital Rx is executing its mission through the deployment of JUDI®, the company's cloud-native enterprise health platform, and a Single-Ledger Modeltm, which increases visibility and reduces variability in drug prices. JUDI connects every aspect of the pharmacy ecosystem in one efficient, scalable platform, servicing millions of members for Medicare, Medicaid, and commercial plans. Together with its clients, Capital Rx is reimagining the administration of pharmacy benefits and rebuilding trust in healthcare. To learn more, visit capital-rx.com.

Media Contacts
?Michael Passanante, SVP, Marketing & Communications
Justin Venneri, Director of Communications
[email protected]

SOURCE Capital Rx

These press releases may also interest you

at 05:45
The global pediatric cardiology market is projected to total a valuation of nearly US$ 4.3 billion in 2024. During the forthcoming forecast period, the ecosystem is...

at 05:15
The micropump market was projected to attain US$ 1.9 billion in 2023. It is likely to garner an 18.7% CAGR from 2024 to 2034, and by 2034, the market is expected to attain US$ 12.4 billion.  Innovations in micropump technologies, including the...

at 05:00
A new study by scientists at deCODE Genetics, subsidiary of Amgen, shows that sequence variants drive the correlation between DNA methylation and gene expression. The same variants are linked to various diseases as well as other human traits....

at 05:00
NuclearN, a leading innovator in the nuclear industry, is proud to highlight its platform designed by nuclear engineers for nuclear engineers to manage outage schedules. The platform enhances efficiency, compliance, and cost-effectiveness in nuclear...

at 04:35
Gilead Sciences, Inc. today announced full efficacy and safety results from its pivotal, Phase 3 PURPOSE 1 trial. Detailed data from the trial's interim analysis announced in June showed that lenacapavir, the company's twice-yearly injectable HIV-1...

at 03:09
Ricovr Healthcare is proud to announce that it has been awarded a competitive Small Business Innovation Research grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) for the development of its...

News published on and distributed by: